Pharmacoeconomic analysis of pertussis booster dose in adolescents in Bulgaria

References

• Winter K, Harriman K. Risk markers for pertussis among infants <4 months of age: Understanding the hispanic disparity. Pediatr Infect Dis J. 2018;37(2):126–131.
   PubMed Web of Science ®Google Scholar
• Heininger U. Early prevention of pertussis is key. Lancet Infect Dis. 2019;19(7):689.
   PubMed Web of Science ®Google Scholar
• Heininger U, André P, Chlibek R, et al. Comparative epidemiologic characteristics of pertussis in 10 Central and Eastern european countries, 2000–2013. PLoS One. 2016;11(6):e0155949.
   PubMed Web of Science ®Google Scholar
• Raycheva R, Stoilova Y, Kevorkyan A, et al. Epidemiological prognosis of pertussis incidence in Bulgaria. Folia Med (Plovdiv). 2020;62(3):509–514.
   PubMedGoogle Scholar
• ECDC Bulgaria: Recommended vaccinations. Date of last update: 27 October 2021. Available from: https://vaccine-schedule.ecdc.europa.eu/.
   Google Scholar
• WHO Routine immunization profile Bulgaria, 2019. 2021. Available from: https://www.euro.who.int/.
   Google Scholar
• Anonnymous. Bulgaria. 2021. Available from: https://www.sabin.org/immunization-policy-bulgaria.
   Google Scholar
• Knoema: Bulgaria - immunization against DPT as a share of children ages 12–23 months, 2019. 2021. Available from: https://knoema.com/atlas/Bulgaria/topics/Health/Health-Service-Coverage/Immunization-against-DPT.
   Google Scholar
• National Center of Infectious and Parasitic Diseases (NCIPD). Reports on the number of infectious diseases by year. 2021. Available from: https://www.ncipd.org.
   Google Scholar
• Knoema: Bulgaria - Pertussis reported cases, 2020. 2021. Available from: https://knoema.com/atlas/Bulgaria/topics/Health/Communicable-Diseases/Pertussis-cases.
   Google Scholar
• NSI: National Statistics Institute database. 2020. Available from: https://www.nsi.bg/en.
   Google Scholar
• Dalby T, Harboe ZB, Krogfelt KA. Seroprevalence of pertussis among danish patients with cough of unknown etiology. Clin Vaccine Immunol. 2010;17(12):2016–2023.
   PubMedGoogle Scholar
• Cosnes-Lambe C, Raymond J, Chalumeau M, et al. Pertussis and respiratory syncytial virus infections. Eur J Pediatr. 2008;167(9):1017–1019.
   PubMed Web of Science ®Google Scholar
• Kandeil W, Atanasov P, Avramioti D, et al. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines. 2019;18(5):439–455.
   PubMed Web of Science ®Google Scholar
• Wiley KE, Zuo Y, Macartney KK, et al. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine. 2013;31(4):618–625.
   PubMed Web of Science ®Google Scholar
• Schellekens J, von König C-HW, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J. 2005;24(5 Suppl):S19–S24.
   PubMedGoogle Scholar
• Vlkova E, Gospodinova M. Severe pertussis in an infant. SSM. 2020;51(2):38–40.
   Google Scholar
• Koytcheva E, Philipov D. Bulgaria: Ethnic differentials in rapidly declining fertility. DemRes. 2008;19:361–402.
   Google Scholar
• Traykov T, Tsvetkov K. Trends and specifics in the reproductive behaviour of the bulgarian population at the beginning of the 21-st century. J Bulg Geograph Soc. 2019;41:43–47.
   Google Scholar
• Forsyth K, Plotkin S, Tan T, et al. Strategies to decrease pertussis transmission to infants. Pediatrics. 2015;135(6):e1475-82–e1482.
   PubMed Web of Science ®Google Scholar
• Freitas AC, Okano V, Pereira JCR. Pertussis booster vaccine for adolescents and young adults in são paulo. Brazil. Rev Saúde Pública. 2011;45(6):1062–1071.
   Google Scholar
• Gilley M, Goldman RD. Protecting infants from pertussis. Can Fam Physician. 2014;60(2):138–140.
   PubMed Web of Science ®Google Scholar
• Wendelboe A, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26(4):293–299.
   PubMed Web of Science ®Google Scholar
• Quinn HE, McIntyre PB. The impact of adolescent pertussis immunization, 2004–2009: lessons from Australia. Bull World Health Organ. 2011;89(9):666–674.
   PubMed Web of Science ®Google Scholar
• Skoff TH, Cohn AC, Clark TA, et al. Early impact of the US tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med. 2012;166(4):344–349.
   PubMedGoogle Scholar
• Halperin SA. Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States. Pediatr Infect Dis J. 2005;24:141–146.
   PubMed Web of Science ®Google Scholar
• Liko J, Robison SG, Cieslak PR. Pertussis vaccine performance in an epidemic year-Oregon, 2012. Clin Infect Dis. 2014;59(2):261–263.
   PubMed Web of Science ®Google Scholar
• Schwartz K, Kwong J, Deeks S, et al. Effectiveness of pertussis vaccination and duration of immunity. CMAJ. 2016;188(16):E399–E406.
   PubMed Web of Science ®Google Scholar
• WHO vaccine-preventable diseases: monitoring system. 2020 global summary (Bulgaria). 2020 (data as of October12, 2020). Available from: https://apps.who.int.
   Google Scholar
• GHO: The Global Health Observatory (Bulgaria). 2020. Available from: https://www.who.int.
   Google Scholar
• Rendi-Wagner P, Tobias J, Moerman L, et al. The seroepidemiology of Bordetella pertussis in Israel-Estimate of incidence of infection. Vaccine. 2010;28(19):3285–3290.
   PubMed Web of Science ®Google Scholar
• Esposito S, Principi N, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Vaccine Study Group (EVASG). Immunization against pertussis in adolescents and adults. Clin Microbiol Infect. 2016;22(Suppl 5):S89–S95.
   PubMedGoogle Scholar
• Di Mattia G, Nicolai A, Frassanito A, et al. Pertussis: new preventive strategies for an old disease. Paediatr Respir Rev. 2019;29:68–73.
   PubMed Web of Science ®Google Scholar
• Baxter R, Bartlett J, Fireman B, et al. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics. 2017;139(5):e20164091.
   PubMed Web of Science ®Google Scholar
• Fernandes EG, Rodrigues C, Sartori A, et al. Economic evaluation of adolescents and adults’ pertussis vaccination: a systematic review of current strategies. Hum Vaccin Immunother. 2019;15(1):14–27.
   PubMed Web of Science ®Google Scholar
• Hallander HO, Nilsson L, Gustafsson L. Is adolescent pertussis vaccination preferable to natural booster infections? Expert Rev Clin Pharmacol. 2011;4(6):705–711.
   PubMedGoogle Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA. 2014;111(2):787–792.
   PubMed Web of Science ®Google Scholar
• Chit A, Zivaripiran H, Shin T, et al. Acellular pertussis vaccines effectiveness over time: a systematic review, Meta-analysis and modeling study. PLoS One. 2018;13(6):e0197970.
   PubMed Web of Science ®Google Scholar
• Solans L, Locht C. The role of mucosal immunity in pertussis. Front Immunol. 2018;9:3068.
   PubMed Web of Science ®Google Scholar
• Zahariev B, Georgieva L. ESPN thematic report: inequalities in access to healthcare. Bulgaria 2018. European Social Policy Network (ESPN). European Commission, 2018. Available from: https://ec.europa.eu.
   Google Scholar
• Purdy KW, Hay JW, Botteman MF, et al. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a Cost-Benefit analysis. Clin Infect Dis. 2004;39(1):20–28.
   PubMed Web of Science ®Google Scholar